So you are not mentioning the antiviral properties of povidone-iodine but concentrating on the antimicrobial properties in the current marketing pitch. Thus not seeing Viraleze or Sanotize/Enovid or Paxlovid or Lagevrio as competitors of community based antiviral treatments for SARS-CoV-2.
So you are not mentioning the antiviral properties of...
Add FRE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.81M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 345684 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 123521 | 2 |
View Market Depth
| Last trade - 16.12pm 20/01/2025 (20 minute delay) ? |
| FRE (ASX) Chart |
Day chart unavailable